11q23.3/11q24.3 gene deletion detection probe (11q23.3/11q24.3)

11q23.3/11q24.3 gene deletion detection probe Detection Kit (Fluorescence In Situ Hybridization Method). - 100µL/10 Tests

Translocations in bands 11q23.3-11q24 are associated with several human cancers, including acute lymphoid and acute myeloid leukemias (AML) and Ewing's sarcoma. 

• 11q23.3/11q24.3
• 100µL/10 Tests

Product Main Components

The kit consists of 11q23.3/11q24.3 dual color probe

Product Intended Use
This kit performs in situ hybridization staining on the basis of conventional staining to provide physicians with auxiliary information for diagnosis. The test results are for clinical reference only and should not be used as the only basis for clinical diagnosis. Clinicians should make comprehensive judgment on the test results based on factors such as the patient’s condition, drug indications, treatment response and other laboratory test indicators.

Detection Principle
Fluorescence in situ hybridization is a technique for directly observing specific nucleic acids in cells in vitro. According to the principle of complementary base pairing, a specific probe is complementary to the target sequence in the cell. Because the probe is fluorescent, the
hybridization probe and the target sequence can be clearly observed under a fluorescence microscope under the appropriate excitation light and the genetic status is observed.